| scholarly article | Q13442814 |
| P2093 | author name string | E Johnson | |
| F Tedesco | |||
| C Casarsa | |||
| H Langeggen | |||
| M Pausa | |||
| P2860 | cites work | Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 |
| Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria | Q29616614 | ||
| Two distinct abnormalities in patients with C8 alpha-gamma deficiency. Low level of C8 beta chain and presence of dysfunctional C8 alpha-gamma subunit | Q34260629 | ||
| Regulation of the synthesis of C1 subcomponents and C1-inhibitor | Q34340423 | ||
| Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. | Q35264401 | ||
| The third component of complement is transcribed and secreted by cultured human endothelial cells | Q35856227 | ||
| Interferon gamma induces synthesis of complement alternative pathway proteins by human endothelial cells in culture | Q36355520 | ||
| Complement biosynthesis by the human hepatoma-derived cell line HepG2 | Q36987205 | ||
| Mononuclear phagocytes have the potential to synthesize the complete functional complement system | Q39643657 | ||
| Effect of cytokines on the secretion of the fifth and eighth complement components by HepG2 cells | Q41498663 | ||
| Endothelial cells in physiology and in the pathophysiology of vascular disorders | Q41757874 | ||
| Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9. | Q41762392 | ||
| The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity | Q41923727 | ||
| In vitro biosynthesis of complement factor I by human endothelial cells | Q42459180 | ||
| Biosynthesis of C3 by human mesangial cells. Modulation by proinflammatory cytokines | Q42477501 | ||
| Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma | Q43762567 | ||
| The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum | Q43767406 | ||
| Human umbilical vein endothelial cells synthesize functional C3, C5, C6, C8 and C9 in vitro | Q44091595 | ||
| Complement activation occurs on subendothelial extracellular matrix in vitro and is initiated by retraction or removal of overlying endothelial cells | Q47936495 | ||
| Biosynthesis of complement factor H by human umbilical vein endothelial cells. Regulation by T cell growth factor and IFN-gamma. | Q54357513 | ||
| Molecular bases of combined subtotal deficiencies of C6 and C7: their effects in combination with other C6 and C7 deficiencies | Q55670899 | ||
| Organ-specific contribution to circulating C7 levels by the bone marrow and liver in humans | Q57089607 | ||
| Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by IFN-gamma and IL-1 | Q68416575 | ||
| Expression of complement alternative pathway proteins by endothelial cells. Differential regulation by interleukin 1 and glucocorticoids | Q68428812 | ||
| Synthesis of complement components C5, C6, C7, C8 and C9 in vitro by human monocytes and assembly of the terminal complement complex | Q69629002 | ||
| Biosynthesis and secretion of the third component of complement by human endothelial cells in vitro | Q70341351 | ||
| Interleukin-1 alpha, interleukin 6 and tumor necrosis factor alpha increase the synthesis and expression of the functional alternative and terminal complement pathways by human umbilical vein endothelial cells in vitro | Q71027197 | ||
| How partial C7 deficiency with chronic and recurrent bacterial infections can mimic total C7 deficiency: temporary restoration of host C7 levels following plasma transfusion | Q71446674 | ||
| Human polymorphonuclear leukocytes store large amounts of terminal complement components C7 and C6, which may be released on stimulation | Q72169141 | ||
| Paradoxical reconstitution of complement activity following plasma transfusion of an individual with deficiency of the seventh component of complement | Q72302250 | ||
| Complement component C7. Assessment of in vivo synthesis after liver transplantation reveals that hepatocytes do not synthesize the majority of human C7 | Q72363605 | ||
| Effect of gamma-interferon on the synthesis of the functional alternative and terminal complement pathways by human umbilical vein endothelial cells in vitro | Q72693834 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 69-76 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | The endothelium is an extrahepatic site of synthesis of the seventh component of the complement system | |
| P478 | volume | 121 |
| Q59791600 | Age and Sex-Associated Changes of Complement Activity and Complement Levels in a Healthy Caucasian Population |
| Q24298379 | An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development |
| Q51076481 | Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. |
| Q40669247 | Cloning and characterization of human complement component C7 promoter. |
| Q33425421 | Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions |
| Q33217628 | Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59. |
| Q35182755 | Cross-talk between the complement and the kinin system in vascular permeability |
| Q37077537 | Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium |
| Q52309394 | Extracellular Vesicles: Packages Sent With Complement. |
| Q73343396 | HUVEC take up opsonized zymosan particles and secrete cytokines IL-6 and IL-8 in vitro |
| Q28585139 | Hepatocyte nuclear factor 1alpha controls the expression of terminal complement genes |
| Q56966003 | Hereditary complement C7 deficiency in nine families: Subtotal C7 deficiency revisited |
| Q37456593 | Inherited complement deficiencies and bacterial infections |
| Q45192226 | Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina. |
| Q33962071 | Modulation of complement membrane attack by local C7 synthesis |
| Q28082379 | On the Functional Overlap between Complement and Anti-Microbial Peptides |
| Q33430697 | Post-bone marrow transplant thrombotic microangiopathy |
| Q35927443 | The complement system at the embryo implantation site: friend or foe? |
| Q52953791 | The endothelium as physiological source of properdin: role of wall shear stress. |
| Q35168168 | The interaction between circulating complement proteins and cutaneous microvascular endothelial cells in the development of childhood Henoch-Schönlein Purpura |
| Q37154268 | Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS. |
| Q98177720 | Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics |
Search more.